Abstract
There are differences between heart failure (HF) of women and that of men in terms of epidemiology, pathophysiology, treatment and quality of care. The aim is to analyze the epidemiological profile of women follewed by HEART FAILURE THERAPY UNIT (HFTU) at the cardiology center Ibn Rochd in Casablanca. See how they are optimized therapeutically and demonstrate that the female is an independent prognostic factor. We report a retrospective study composed of 1500 patients followed in HFTU between January 2007-to May 2013. On 1500 patients were 525 women and 975 men. The average age of women was 58±4 years versus 62±4 years in men. 38% of women were diabetic and 36% hypertensive.10% of women had at least one coronary lesion confirmed versus 28% for men. Therapeutically only 45% of women were optimized (full dose of beta-blocker-IEC-spirinolactone) versus 78% in men. After 1 year of follow-up there were 4. The results of our study are similar to those of the few studies and prognosis seems to be better among women, although the mechanism is not well understood.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
